SCOPE-Leukemia

What is the Purpose of this Study?

We are doing this study to determine whether specialty palliative care or primary palliative care is the best way to improve the quality of life and experience of patients and their caregivers.

What is the Condition Being Studied?

Acute Myeloid Leukemia (AML)

Who Can Participate in the Study?

Adults ages 18+ who:

  • Are hospitalized with high-risk AML
  • Are receiving treatment with either intensive chemotherapy (7+3) or modification of this regimen on a clinical trial, or a similar intensive regimen requiring prolonged hospitalization, or hypomethylating agents+/-additional agents or modification of this regimen on a clinical trial

For more information about who can join this study, please contact the study team at isaac.oyediran@duke.edu.

Age Group
Adults

What is Involved?

If you choose to join this study, you will:

  • Fill out study questionnaires about your health and how you are feeling
  • Let us know a caregiver (family member or close friend who is helping you) who may be interested in taking part in the study
  • Receive primary palliative care during your current and future hospital stay by trained oncology clinicians

Study Details

Full Title
PROTOCOL TITLE: Specialty Compared to Oncology Delivered Palliative Care for Patients with Acute Myeloid Leukemia – SCOPE-Leukemia
Principal Investigator
Associate Professor of Medicine
Protocol Number
IRB: PRO00110266
NCT: NCT05237258
Phase
Phase N/A
ClinicalTrials.gov
Enrollment Status
OPEN TO ACCRUAL
Participate